Peppermint oil.

Complementary and Alternative Research and Education (CARE) Program, Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.
Pediatrics in Review (Impact Factor: 0.82). 08/2006; 27(7):e49-51.
Source: PubMed
  • [Show abstract] [Hide abstract]
    ABSTRACT: Isolated gastric varices with upper gastrointestinal bleeding are an unusual event, particularly in children in whom obstruction of the splenic vein is an infrequent occurrence. We describe a 19-year-old man with bleeding isolated gastric varices 11 years after he underwent distal pancreatectomy with preservation of the spleen for a ruptured pancreatic pseudocyst. The disorder was cured with splenectomy.
    Journal of Pediatric Surgery 01/2011; 46(1):e33-5. DOI:10.1016/j.jpedsurg.2010.08.066 · 1.31 Impact Factor
  • Pediatrics in Review 11/2012; 33(11):509-17. DOI:10.1542/pir.33-11-509 · 0.82 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Irritable bowel syndrome (IBS) is a common gastrointestinal disorder with a high incidence in the general population. The diagnosis of IBS is mainly based on exclusion of other intestinal conditions through the absence of inflammatory markers and specific antigens. The current pharmacological treatment approaches available focus on reducing symptom severity while often limiting quality of life because of significant side effects. This has led to an effectiveness gap for IBS patients that seek further relief to increase their quality of life. Complementary and alternative medicines (CAM) have been associated with a higher degree of symptom management and quality of life in IBS patients. Over the past decade, a number of important clinical trials have shown that specific herbal therapies (peppermint oil and Iberogast(®)), hypnotherapy, cognitive behavior therapy, acupuncture, and yoga present with improved treatment outcomes in IBS patients. We propose an integrative approach to treating the diverse symptoms of IBS by combining the benefits of and need for pharmacotherapy with known CAM therapies to provide IBS patients with the best treatment outcome achievable. Initial steps in this direction are already being considered with an increasing number of practitioners recommending CAM therapies to their patients if pharmacotherapy alone does not alleviate symptoms sufficiently.
    World Journal of Gastroenterology 01/2014; 20(2):346-362. DOI:10.3748/wjg.v20.i2.346 · 2.43 Impact Factor